Telomerase levels change in OFFER study
Published: 2 August 2017| Version 1 | DOI: 10.17632/csz5rw8fyk.1
Contributors:
Tomasz Pawelczyk,
Marta Grncow-Grabka,
Elżbieta Trafalska,
Janusz Szemraj,
Natalia Żurner,
Agnieszka Pawełczyk
Description
Changes in telomerase levels during 26-weeks supplementation of n-3 PUFA or placebo (olive oil) in first-episode schizophrenia patients.
Files
Categories
Psychiatry, Schizophrenia, Telomerase